MergerLinks
Menu
  • For Principals
  • For Advisors
  • News
  • Log in
  • Sign Up
  • For Principals
  • For Advisors
  • News
  • Log in
  • Sign Up
Explore Previous Editions
Never miss a deal
Daily Review is our daily roundup of M&A news. Announcements, rumors, insights, and data before your morning coffee. Subscribe and never miss a beat with MergerLinks.
28 April 2026

Sun Pharma to acquire Organon for $11.75bn.​

Daily Review

2025 Dealmakers Rankings
Top Highlights
 
Shell to acquire ARC Resources for $16.4bn.
 
Shell, a British multinational oil and gas company, agreed to acquire ARC Resources, an energy company focused on the Montney shale basin in British Columbia and Alberta, Canada, for $16.4bn, according to press releases.
 
ARC Resources is advised by RBC Capital Markets, Baker Botts, Burnet Duckworth & Palmer and Freshfields. Shell is advised by Goldman Sachs, according to press releases.
 
Sun Pharma to acquire Organon for $11.75bn.​

Sun Pharma, a company specializing in generic pharmaceuticals, agreed to acquire Organon, an American pharmaceutical company, for $11.75bn, according to press releases.

Sun Pharma is advised by JP Morgan, Jefferies & Company, AZB & Partners and White & Case. Debt financing is provided by Citigroup, JP Morgan and MUFG Bank. Organon is advised by Goldman Sachs, Morgan Stanley, Cyril Amarchand Mangaldas and Sullivan & Cromwell (led by Scott B. Crofton and Alison S. Ressler), according to press releases and MergerLinks data.
 
Astorg Partners to acquire the microbiology business of Thermo Fisher Scientific for $1.075bn.
 
Astorg Partners, a pan-European private equity firm, agreed to acquire the microbiology business of Thermo Fisher Scientific, an American life science and clinical research company, for $1.075bn, according to press releases.
 
Astorg Partners is advised by Evercore, Moelis & Co, Latham & Watkins (led by David Beller and Leah Sauter), Prosek Partners and Steele and Holt. Thermo Fisher Scientific is advised by Perella Weinberg Partners, Wells Fargo Securities, Axinn Veltrop & Harkrider, Cravath Swaine & Moore and Hogan Lovells, according to press releases.
 
Deal Round up
 
AMERICAS
 
Ligand to acquire XOMA for $739m.
 
Real to acquire REMAX for $880m.
 
Eli Lilly to acquire Ajax Therapeutics for up to $2.3bn.
 
Suzu Labs completes the acquisition of Emulated Criminals.
 
Avery Dennison to invest $75m in Wiliot.
 
Granite completes the acquisition of Kenny Seng Construction.
 
HawkEye targets $2.4bn valuation in US IPO. (Press Release)
 
Seaport and Hemab launch US IPOs amid market rebound. (Reuters)
 
EMEA
 
Bridgepoint to acquire a majority stake in iC Consult from The Carlyle Group.
 
Apollo to acquire the interiors business group of Forvia for €1.82bn.
 
Critical Metals to acquire European Lithium for $835m.
 
Shackleton Advisers to acquire Hurst Point Group from The Carlyle Group.
 
Apollo completes the investment in vVARDIS.
 
Berkeley Research Group completes the acquisition of E.CA Economics.
 
Lifeline Ventures leads a $117m funding round in Verda.
 
Germany sounded out banks as Commerzbank white knights. (Bloomberg)
 
APAC
 
IFM Investors to acquire the remaining 65.52% stake in Atlas Arteria from Lazard Asset Management, BlackRock, and State Street for AUD4.5bn.
 
Daiwa Securities to acquire ORIX Bank from ORIX for JPY370bn.
 
Chinese regulators block Meta's acquisition of Manus. (Bloomberg)
 
China Merchants joins talks for CK Hutchison ports sale. (Bloomberg)
 
Denso weighs withdrawal of Rohm takeover bid. (Bloomberg)
 
Singularity Growth in talks to invest in Bodycraft. (DealStreetAsia)
 
CATL launches $5bn Hong Kong share sale. (Reuters)
 
Acko hires banks for $350m India IPO. (Bloomberg)
COMPANIES
Ajax Therapeutics
ARC Resources
Atlas Arteria
Avery Dennison
Berkeley Research
CATL
CK Hutchison
Commerzbank
Critical Metals
Denso
Eli Lilly
European Lithium
FORVIA
Granite
HawkEye 360
Hurst Point
IC Consult
Lazard AM
Ligand
Manus
Meta
Organon
RE/MAX
Real Brokerage
Shackleton
Shell
State Street
Sun Pharma
Thermo Fisher
UniCredit
Wiliot
XOMA Royalty

INVESTORS
Apollo
Astorg Partners
BlackRock
Bridgepoint
Carlyle
Daiwa Securities
General Atlantic
IFM Global
IFM Investors
Lifeline
ORIX
TESI

FINANCIAL ADVISORS 
Canaccord Genuity
Cantor Fitzgerald
Citigroup
Credit Agricole
Evercore
EY
Flagstaff
Goldman Sachs
HC Wainwright
ICICI
Jefferies
JP Morgan
Kotak
Leerink Partners
Lincoln
Marsh
Moelis & Co
Morgan Stanley
Piper Sandler
Poynton Stavrianou
PwC
PWP
RBC Capital
Rothschild & Co
Stifel
UBS
UniCredit
Wells Fargo
 
LEGAL ADVISORS
Axinn
AZB & Partners
Baker Botts
Baker McKenzie
BD&P
Cleary Gottlieb
Cooley
Cravath Swaine
Cyril Amarchand
Freshfields
Gibson Dunn
Gowling WLG
Hogan Lovells
King & Wood Mallesons
Kirkland & Ellis
Latham & Watkins
Linklaters
Morrison & Foerster
Paul Hastings
Paul Weiss
Proskauer Rose
Ropes & Gray
Steinepreis Paganin
Sullivan & Cromwell
White & Case
Willkie Farr
 
PR ADVISORS
Argot Partners
Collected Strategies
FGS Global
Greentarget
H/Advisors Abernathy
Joele Frank
KV Management
Madison Alexander
Prosek Partners
Steele and Holt
Yates Network
 
DEBT PROVIDERS
Apollo
Citigroup
JP Morgan
Morgan Stanley
MUFG Bank
 
Read on...
Scroll down to read deal descriptions. Your suggestions and comments support the democratisation of M&A data. If you'd like to contribute to the future editions, drop us a line.
 
AMERICAS
 
Ligand to acquire XOMA for $739m.

Ligand, a biopharmaceutical company, agreed to acquire XOMA, a biotechnology royalty aggregator, for $739m, according to press releases.

Ligand is advised by Citigroup, Stifel, Paul Hastings and Collected Strategies (led by Jude Gorman and Nicholas Lamplough). XOMA is advised by HC Wainwright, Leerink Partners, Gibson Dunn & Crutcher, Argot Partners (led by Maghan Meyers) and KV Management (led by Kathy Vincent), according to press releases.
 
Real to acquire REMAX for $880m.
 
Real, a technology-powered real estate brokerage, agreed to acquire REMAX, a provider of real estate brokerage services, for $880m, according to press releases.
 
REMAX is advised by JP Morgan, Morrison Foerster and H/Advisors Abernathy (led by Carina Davidson). Real is advised by Morgan Stanley, Gowling WLG, Willkie Farr & Gallagher and Joele Frank. Debt financing is provided by Apollo Global Management and Morgan Stanley, according to press releases.
 
Eli Lilly to acquire Ajax Therapeutics for up to $2.3bn.
 
Eli Lilly, an American multinational pharmaceutical company, agreed to acquire Ajax Therapeutics, a biopharmaceutical company developing next-generation JAK inhibitors for patients with myeloproliferative neoplasms, for up to $2.3bn, according to press releases.
 
Ajax Therapeutics is advised by Cooley, Kirkland & Ellis and The Yates Network (led by Kathryn Morris). Eli Lilly is advised by Ropes & Gray, according to press releases.
 
Suzu Labs completes the acquisition of Emulated Criminals.
 
Suzu Labs, a cybersecurity and artificial intelligence firm focused on secure AI adoption, completed the acquisition of Emulated Criminals, a boutique cybersecurity company specializing in adversary emulation and continuous red teaming, according to press releases. Financial terms were not disclosed.
 
Suzu Labs was advised by Madison Alexander PR (led by Dan Chmielewski), according to press releases.
 
Avery Dennison to invest $75m in Wiliot.
 
Avery Dennison, a global materials science and digital identification solutions company, agreed to invest $75m in Wiliot, a supply chain AI platform, according to press releases.
 
Granite completes the acquisition of Kenny Seng Construction.
 
Granite, a civil construction company and aggregate producer, completed the acquisition of Kenny Seng Construction, a Utah-based construction company, according to press releases. Financial terms were not disclosed.
 
HawkEye targets $2.4bn valuation in US IPO. (Press Release)

HawkEye 360 is targeting a valuation of up to $2.4bn in its US IPO as it seeks to capitalize on improving market conditions.

The company aims to raise up to $416m through the offering as it advances its listing plans and taps investor demand.
 
Seaport and Hemab launch US IPOs amid market rebound. (Reuters)

Seaport Therapeutics and Hemab Therapeutics have launched US IPOs as biotech listings gain momentum and investor appetite strengthens.

The offerings reflect improving sentiment and a broader revival in US capital markets activity.
 
EMEA
 
Bridgepoint to acquire a majority stake in iC Consult from The Carlyle Group.
 
Bridgepoint, a mid-market investment firm, agreed to acquire a majority stake in iC Consult, an independent provider of identity security services, from The Carlyle Group, a private equity firm, according to press releases. Financial terms were not disclosed.
 
iC Consult is advised by PricewaterhouseCoopers, McKinsey & Company, Lincoln International and Latham & Watkins. Bridgepoint is advised by Ernst & Young, Altman Solon, Canaccord Genuity, Marsh, Piper Sandler and Kirkland & Ellis, according to press releases.
 
Apollo to acquire the interiors business group of Forvia for €1.82bn.

Apollo, an alternative investment manager, agreed to acquire the interiors business group of Forvia, a global automotive technology supplier, for €1.82bn ($2.1bn), according to press releases.

Apollo is advised by UBS, UniCredit and Kirkland & Ellis (led by Vincent Ponsonnaille). UBS and UniCredit are advised by Paul Weiss Rifkind Wharton & Garrison. Forvia is advised by Credit Agricole, Evercore and Baker McKenzie, according to press releases.
 
Critical Metals to acquire European Lithium for $835m.

Critical Metals, a mining development company, agreed to acquire European Lithium, a mining exploration and development company, for $835m, according to press releases. 

Critical Metals is advised by Cantor Fitzgerald, Cleary Gottlieb Steen & Hamilton and Nova Legal. European Lithium is advised by Poynton Stavrianou and Steinepreis Paganin, according to press releases. 
 
Shackleton Advisers to acquire Hurst Point Group from The Carlyle Group.
 
Shackleton Advisers, a British financial adviser, agreed to acquire Hurst Point Group, a UK-based wealth management group, from The Carlyle Group, a private equity firm, according to press releases. Financial terms were not disclosed.
 
Hurst Point Group is advised by Rothschild & Co and Linklaters. Shackleton Advisers is advised by Evercore and Proskauer Rose, according to press releases.
 
Apollo completes the investment in vVARDIS.

Apollo, an alternative investment manager, completed the investment in vVARDIS, a dental med‑tech company, according to press releases. Financial terms were not disclosed.

vVARDIS was advised by FGS Global (led by Stephanie Blank), according to press releases. 
 
Berkeley Research Group completes the acquisition of E.CA Economics.

Berkeley Research Group, a global consulting firm, completed the acquisition of E CA Economics, a competition economics consultancy, according to press releases. Financial terms were not disclosed.

Berkeley Research Group was advised by Greentarget, according to press releases.
 
Lifeline Ventures leads a $117m funding round in Verda.
 
Lifeline Ventures, a venture capital firm, led a $117m funding round in Verda, a European provider of cloud infrastructure for frontier, sovereign, and sustainable AI, with participation from byFounders, Tesi and Varma, according to press releases.
 
Germany sounded out banks as Commerzbank white knights. (Bloomberg)

German officials explored options with European lenders to defend Commerzbank against UniCredit’s takeover bid, including potential stake purchases or a rival offer.

The discussions remained highly preliminary and did not advance beyond early-stage exploratory contacts.
 
APAC
 
IFM Investors to acquire the remaining 65.52% stake in Atlas Arteria from Lazard Asset Management, BlackRock, and State Street for AUD4.5bn.

IFM Investors, an investment manager, offered to acquire the remaining 65.52% stake in Atlas Arteria, an international toll road owner and operator, from Lazard Asset Management, BlackRock, and State Street for AUD4.5bn ($3.2bn), according to press releases.

Atlas Arteria is advised by Aix Advisory (led by David Luff), Flagstaff Partners, UBS and King & Wood Mallesons, according to press releases.
 
Daiwa Securities to acquire ORIX Bank from ORIX for JPY370bn.

Daiwa Securities, a Japanese investment bank, agreed to acquire ORIX Bank, a Japan‑based internet bank, from ORIX, a diversified financial services firm, for JPY370bn ($2.3bn), according to press releases.
 
Chinese regulators block Meta's acquisition of Manus. (Bloomberg)
 
China's National Development and Reform Commission announced its decision to prohibit Meta's acquisition of Manus, an agentic AI startup.
 
The decision was made in accordance with laws and regulations, the powerful state planner said in a one-line notice.
 
China Merchants joins talks for CK Hutchison ports sale. (Bloomberg)

China Merchants Group is in discussions to join a consortium seeking to acquire dozens of ports from CK Hutchison, reviving momentum for the stalled deal.

The company could support China Cosco Shipping in financing the transaction as both groups pursue the rare opportunity to acquire a large global port portfolio.
 
Denso weighs withdrawal of Rohm takeover bid. (Bloomberg)

Denso is considering withdrawing its proposal to acquire power semiconductor maker Rohm, potentially ending a deal valued at over $9bn.

The companies have been unable to agree on terms, with discussions failing to secure Rohm’s support for the transaction.
 
Singularity Growth in talks to invest in Bodycraft. (DealStreetAsia)

Singularity Growth is in discussions to invest in Indian wellness chain Bodycraft as it expands its presence in consumer services.

The deal reflects growing investor interest in scalable premium personal care platforms as demand continues to rise across India.
 
CATL launches $5bn Hong Kong share sale. (Reuters)

CATL has launched a roughly $5bn Hong Kong share sale, seeking to capitalize on strong share price performance following its recent listing.

The offering is priced at a discount to the current market level as the company taps investor demand and market liquidity.
 
Acko hires banks for $350m India IPO. (Bloomberg)

General Atlantic-backed Acko has appointed Kotak, ICICI Securities and Morgan Stanley for a potential IPO that could raise up to $350m.

The company is targeting a valuation of up to $2.5bn as it advances preparations for a potential public listing.

 

Connect the World of Dealmakers

Expand your network of fellow Dealmakers by inviting your colleagues and coworkers.

Join Now

If you know someone who might enjoy this briefing forward this email. Subscribe to a Daily Review.

Who we serve
  • Executives & Investors
  • Advisors
Insights
  • News
  • Top Dealmakers
  • Top Firms
Legal
  • Terms & Conditions
  • Privacy Policy
  • Disclaimer
MergerLinks Limited
  • 20-22 Wenlock Road London N1, 7GU England
© MergerLinks Limited 2019